Prohibix is developing the next generation of injectable hyaluronic acid and hyaluronic acid combination products designed to improve patient lives. Our platform HYALUTE™ crosslinking technology enables precise control of hydrogel mechanics, duration in the body, and drug release in order to address unmet clinical needs.